![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print September 17, 2001
Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pitttsburgh, PA 15261
Corresponding Author: nabrad{at}pitt.edu
The cystic fibrosis transmembrane conductance regulator (CFTR) contains a conserved tyrosine-based internalization motif, Y1424DSI, which interacts with the endocytic clathrin adaptor complex, AP-2, and is required for its efficient endocytosis. Although direct interactions between several endocytic sequences and the medium chain and endocytic clathrin adaptor complexes has been shown by protein-protein interaction assays, whether all these interactions occur in vivo or are physiologically important has not always been addressed. Here we show, using both in vitro and in vivo assays, a physiologically relevant interaction between CFTR and the m subunit of AP-2. Crosslinking experiments were performed using photoreactive peptides containing the YDSI motif and purified adaptor complexes. CFTR peptides crosslinked a 50 kDa subunit of purified AP-2 complexes, the apparent molecular weight of m2. Furthermore, isolated m2 bound to the sorting motif, YDSI, both in crosslinking experiments and GST-pulldown experiments, confirming that m2 mediates the interaction between CFTR and AP-2 complexes. Inducible overexpression of dominant-negative m2 in HeLa cells results in AP-2 complexes that fail to interact with CFTR. Moreover, internalization of CFTR in mutant cells is greatly reduced compared to wild type HeLa cells. These results indicate that the AP-2 endocytic complex selectively interacts with the conserved tyrosine-based internalization signal in the carboxyl terminus of CFTR, YDSI. Furthermore, this interaction is mediated by the m2 subunit of AP-2 and mutations in m2 that block its interaction with YDSI inhibit the incorporation of CFTR into the clathrin-mediated endocytic pathway.
J. Biol. Chem, 10.1074/jbc.M104545200
Submitted on May 18, 2001
Revised on August 27, 2001
Accepted on September 14, 2001
mu2 binding directs the cystic fibrosis transmembrane conductance regulator to the clathrin mediated endocytic pathway
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Jurkuvenaite, K. Varga, K. Nowotarski, K. L. Kirk, E. J. Sorscher, Y. Li, J. P. Clancy, Z. Bebok, and J. F. Collawn Mutations in the Amino Terminus of the Cystic Fibrosis Transmembrane Conductance Regulator Enhance Endocytosis J. Biol. Chem., February 10, 2006; 281(6): 3329 - 3334. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Guggino and S. P. Banks-Schlegel Macromolecular Interactions and Ion Transport in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 815 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gentzsch, X.-B. Chang, L. Cui, Y. Wu, V. V. Ozols, A. Choudhury, R. E. Pagano, and J. R. Riordan Endocytic Trafficking Routes of Wild Type and {Delta}F508 Cystic Fibrosis Transmembrane Conductance Regulator Mol. Biol. Cell, June 1, 2004; 15(6): 2684 - 2696. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Walker, H. B. Jijon, T. Churchill, M. Kulka, and K. L. Madsen Activation of AMP-activated protein kinase reduces cAMP-mediated epithelial chloride secretion Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G850 - G860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Picciano, N. Ameen, B. D. Grant, and N. A. Bradbury Rme-1 regulates the recycling of the cystic fibrosis transmembrane conductance regulator Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1009 - C1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bertrand and R. A. Frizzell The role of regulated CFTR trafficking in epithelial secretion Am J Physiol Cell Physiol, July 1, 2003; 285(1): C1 - C18. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Diviani, A.-L. Lattion, L. Abuin, O. Staub, and S. Cotecchia The Adaptor Complex 2 Directly Interacts with the {alpha}1b-Adrenergic Receptor and Plays a Role in Receptor Endocytosis J. Biol. Chem., May 23, 2003; 278(21): 19331 - 19340. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Hallows, G. P. Kobinger, J. M. Wilson, L. A. Witters, and J. K. Foskett Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1297 - C1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Silvis, J. A. Picciano, C. Bertrand, K. Weixel, R. J. Bridges, and N. A. Bradbury A Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Generates a Novel Internalization Sequence and Enhances Endocytic Rates J. Biol. Chem., March 21, 2003; 278(13): 11554 - 11560. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, J. C. Clark, B. J. Aronow, C. R. Dey, C. Liu, J. L. Wooldridge, and J. A. Whitsett Transcriptional Adaptation to Cystic Fibrosis Transmembrane Conductance Regulator Deficiency J. Biol. Chem., February 21, 2003; 278(9): 7674 - 7682. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Peter, K. Varga, Z. Bebok, C. M. McNicholas-Bevensee, L. Schwiebert, E. J. Sorscher, E. M. Schwiebert, and J. F. Collawn Ablation of Internalization Signals in the Carboxyl-terminal Tail of the Cystic Fibrosis Transmembrane Conductance Regulator Enhances Cell Surface Expression J. Biol. Chem., December 13, 2002; 277(51): 49952 - 49957. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |